May 29, 2017 / 2:32 PM / 7 months ago

BRIEF-Peptonic Medical announces additional results of completed phase 2b study​

May 29 (Reuters) - PEPTONIC MEDICAL AB

* PEPTONIC MEDICAL‘S VAGINAL GEL SHOWS AN EXCELLENT SAFETY PROFILE AND REDUCES SYMPTOMS ASSOCIATED WITH URINARY INCONTINENCE

* ADDITIONAL RESULTS OF COMPLETED PHASE 2B STUDY SHOW THAT VAGINAL GEL WITHOUT OXYTOCIN IS WELL TOLERATED AND ITS USE DOESN‘T CAUSE ANY SERIOUS ADVERSE EVENTS (SAE)​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below